Dynamic quotes: Off
|
ETFs with MRK as a Top 10 Holding*Sponsored by:
| Weighting | ETF Name (Symbol) | 100-Day Price Change (%) |
|---|---|---|
| 8.53% | First Trust Morningstar Dividend Leaders Index Fund (FDL) | +3.25 (17.83%) |
| 8.36% | iShares Dow Jones U.S. Pharmaceutical Index Fund (IHE) | +18.79 (22.37%) |
| 7.72% | Select Sector SPDR Fund - Health Care (XLV) | +9.81 (24.86%) |
| 7.26% | iShares Dow Jones U.S. Health Care Index Fund (IYH) | +20.92 (25.36%) |
| 7.23% | Merrill Lynch Pharmaceutical HOLDRS (PPH) | +8.03 (20.41%) |
|
||
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Merck & Co., Inc. (“Merck” or the “Company”) is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company’s operations are principally managed on a products basis and are comprised of four operating segments, which are the Pharmaceutical, Animal Health, Consumer Care and Alliances segments, and one reportable segment, which is the Pharmaceutical segment. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. ... More ...
Consensus Recommendation |
|
Analyst Info |
|
| Annual EPS Est: | $3.82 |
| Quarterly EPS Est: | 0.83 |
| PEG Ratio: | 5.18 |
|
Mean Recommendation: View Summary / View All |
1.81 |
Data is provided by Zacks Investment Research